BWMN · Bowman Consulting Group Ltd.

Reflects shares sold under a Rule10b5-1 trading plan that was adopted on December 12, 2025. The Rule 10b5-1 trading plan provides for the sale of up to 7500 shares of common stock from May 2026 through December 2026.

Represents the annual award of restricted stock made to non-employee directors on May 27, 2026. The award vests one year from the grant date subject to continued service on the Board of Directors.

Represents the annual award of restricted stock made to non-employee directors on May 27, 2026. The award vests one year from the grant date subject to continued service on the Board of Directors.

Represents the annual award of restricted stock made to non-employee directors on May 27, 2026. The award vests one year from the grant date subject to continued service on the Board of Directors.

Represents the annual award of restricted stock made to non-employee directors on May 27, 2026. The award vests one year from the grant date subject to continued service on the Board of Directors.

Represents the annual award of restricted stock made to non-employee directors on May 27, 2026. The award vests one year from the grant date subject to continued service on the Board of Directors.

Reflects shares sold under a 10b5-1 Plan, adopted on August 27, 2025. The 10b5-1 Plan provides for the sale of up to 1,230 shares of common stock pursuant to the terms of the 10b5-1 Plan during May 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

On February 9, 2023, the reporting person was granted an award of restricted stock units under the 2021 Executive Officers Long Term Incentive Plan, as amended, which vests in the form of common stock based on the total stockholder return of the Issuer compared against a peer group for the performance period January 1, 2023 through December 31, 2025. On February 11, 2026, the Compensation Committee determined that the 26.25th percentile performance level had been met, resulting in the vesting of these shares.

Reflects the annual award of 8,579 shares of time-based restricted stock under the Long-Term Incentive Plan, which vests in three equal installments beginning on the first anniversary of the grant date. In addition, reflects a retention equity award of 5,719 shares of time-based restricted stock, which vests in three equal installments, beginning on the first anniversary of the grant date.

Reflect amount earned by the reporting person under the 2021 Executive Short Term Incentive Plan, as amended, for performance-year ended December 31, 2025, which amounts the reporting person had previously elected to have paid in common stock. The common stock will vest on December 15, 2026.

Reflects the annual award of time-based restricted stock under the Long-Term Incentive Plan, which vests in three equal installments beginning on the first anniversary of the grant date.

Reflect amount earned by the reporting person under the 2021 Executive Short Term Incentive Plan, as amended, for performance-year ended December 31, 2025, which amounts the reporting person had previously elected to have paid in common stock. The common stock will vest on December 15, 2026.

Reflects the annual award of time-based restricted stock under the Long-Term Incentive Plan, which vests in three equal installments beginning on the first anniversary of the grant date.

On February 9, 2023, the reporting person was granted an award of restricted stock units under the 2021 Executive Officers Long Term Incentive Plan, as amended, which vests in the form of common stock based on the total stockholder return of the Issuer compared against a peer group for the performance period January 1, 2023 through December 31, 2025. On February 11, 2026, the Compensation Committee determined that the 26.52nd percentile performance level had been met, resulting in the vesting of these shares.

On February 9, 2023, the reporting person was granted an award of restricted stock units under the 2021 Executive Officers Long Term Incentive Plan, as amended, which vests in the form of common stock based on the total stockholder return of the Issuer compared against a peer group for the performance period January 1, 2023 through December 31, 2025. On February 11, 2026, the Compensation Committee determined that the 26.52nd percentile performance level had been met, resulting in the vesting of these shares.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan adopted on June 10, 2025. The plan provides for the sale of up to 20,000 shares of the Company's common stock pursuant to the terms of the plan from September 2025 through October 2025.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan that was adopted on June 6, 2025. The Rule 10b5-1 trading plan provides for (i) with respect to Mr. Bowman, the sale of up to 112,500 shares of Company common stock, pursuant to the terms of the plan from September 2025 through September 2026, and (ii) with respect to Bowman Family Asset Management LLC ("BFAM"), an estate planning vehicle established to manage the investments of Mr. Bowman and his family and of which Mr. Bowman is manager, the sale of up to 67,500 shares of Company common stock owned by BFAM pursuant to the terms of the plan, from September 2025 through September 2026.

Reflects shares sold under a Rule 10b5-1 trading plan adopted on June 10, 2025. The plan provides for the sale of up to 20,000 shares of the Company's common stock pursuant to the terms of the plan from September 2025 through October 2025.

Reflects shares withheld in payment of tax liability associated with a vesting of time-based restricted stock.

Reflects shares sold under a Rule 10b5-1 trading plan adopted on June 10, 2025. The plan provides for the sale of up to 1,350 shares of the Company's common stock pursuant to the terms of the plan in September 2025.

Reflects shares sold under a Rule 10b5-1 trading plan adopted on June 9, 2025. The plan provides for the sale of up to 3,000 shares of the Company's common stock pursuant to the terms of the plan from September 2025 through August 2026.

Reflects an award of time-based restricted stock vesting on December 15, 2025.

Reflects shares sold under a Rule 10b5-1 trading plan adopted on March 14, 2025. The plan provides for the sale of up to 800 shares of the Company's common stock pursuant to the terms of the plan from June 2025 through July 2025.

Reflects shares sold under a Rule 10b5-1 Plan adopted on May 17, 2024. The Plan provides for the sale of up to 45,000 shares of the Company's common stock pursuant to the terms of the Plan from August 19, 2024 through July 2025.

Reflects shares sold under a Rule 10b5-1 trading plan adopted on March 14, 2025. The plan provides for the sale of up to 800 shares of the Company's common stock pursuant to the terms of the plan from June 2025 through July 2025.

Reflects shares sold under a Rule 10b5-1 trading plan adopted on May 15, 2024. The plan provides for the sale of up to 6,600 shares of the Company's common stock pursuant to the terms of the plan from August 14, 2024 through August 2025.

Represents the annual award of restricted stock made to non-employee directors on May 23, 2025. The award vests one year from the grant date subject to continued service on the Board of Directors.